Home > Newsletters > International Medical Device Regulatory Monitor > EUnetHTA Seeks Input on Breast Cancer Recurrence, Aneurysm Screening Tests
International Medical Device Regulatory Monitor
November 2012 | Vol. 20 No. 11
EUnetHTA Seeks Input on Breast Cancer Recurrence, Aneurysm Screening Tests
Abdominal aorta aneurysm (AAA) screening and prognostic tests for breast cancer recurrence may offer benefits to specific populations, but a lack of data on both may be keeping the European network for Health Technology Assessment (EUnetHTA) from making a clear recommendation on their use.
IMDRF Unveils Global UDI Scheme; Core Concepts Endorsed in EU RecommendationUDI Takes Two Steps Forward With IMDRF Guidance, EU Recommendations on SchemeCentralized Premarket Mechanism Is Not Answer to EU Device Regulation: IndustryEuropean Commission Seeks Comment on Regulation of Advanced Therapies
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.